MedPath

Evaluation of Dutch Integrated Stroke Service Experiments

Completed
Conditions
Ischemic stroke
Circulatory System
Registration Number
ISRCTN67636203
Lead Sponsor
The Netherlands Organisation for Health Research and Development (ZonMw)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
411
Inclusion Criteria

All patients in these experimental settings were compared to similar concurrent patients from general hospitals in three other Dutch regions. The latter were selected from a group of 23 hospitals participating in a previous national study. Based on the data collected in this already completed study, three hospitals were selected as representing the average Dutch patient, receiving the average current level of Dutch stroke care. The criteria for this selection were:
1. The average age of patients
2. Duration of hospital stay
3. Case-fatality
4. Barthel Index at discharge
5. Destination after discharge

All consecutive hospital patients admitted in a region with an acute first or recurrent ischemic stroke or Transient Ischemic Attack (TIA) were included.

Exclusion Criteria

Dead on arrival.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Health-related quality-of-life (QALIES) at two and six months<br>2. Cumulative total societal costs at three months (direct and indirect costs)<br>3. Length-of-stay as the most important cost driver
Secondary Outcome Measures
NameTimeMethod
1. Other neurological health outcomes (Glasgow Coma Scale, 30 item version of the Sickness Impact Profile [SA-SIP30], Cambridge Cognitive Examination, modified Rankin Scale [mRS], The Barthel Index [BI])<br>2. Care satisfaction <br>3. Indirect medical costs<br>4. Residence<br>5. Quality of care<br><br>A qualitative study also observed the characteristics of the regional services.
© Copyright 2025. All Rights Reserved by MedPath